Followers | 437 |
Posts | 42954 |
Boards Moderated | 2 |
Alias Born | 05/08/2006 |
Monday, June 06, 2011 11:37:12 AM
Advanced Voice Recognition Systems, Inc. owns a portfolio of patents and patent-pending applications related to speech recognition technologies. The company’s first US Patent #5,960,447 is for a word tagging and editing system for speech recognition. The patent includes 42 claims covering an extremely broad base of features applicable to existing automatic speech recognition (ASR) products and markets such as smartphones, language translation and large medical transcription systems.
Its second US Patent #7,558,730 covers a system for facilitating speech recognition and transcription among users employing protocols for generating, transcribing and exchanging speech. A third patent was granted to Advanced Voice Recognition Systems which is an extension of this patent. It is expected to improve the company’s efforts to monetize its assets in the rapidly growing voice recognition and transcription marketplace.
On March 9, 2010, the United States Patent and Trademark Office (USPTO) declared an interference between the company as senior party and Allvoice Developments as junior party. An interference is a proceeding conducted by the USPTO in instances where two or more parties claim patent rights to the technology. The USPTO will determine which party invented the technology first and award the patent to that party.
On January 13, 2011, Oblon Spivak represented Advanced Voice Recognition Systems in the interference proceedings between the company and Allvoice. He delivered oral arguments before a three judge panel of the Board of Patent Appeals and Interferences. Advanced Voice Recognition Systems hopes to receive a timely decision.
For more information on Advanced Voice Recognition Systems and its patents, please visit the company’s website at www.avrsys.com
Recent AVOI News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2023 07:52:37 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/16/2023 02:34:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 03:16:03 PM
- Form DEFR14C - Revised information statement materials, definitive • Edgar (US Regulatory) • 07/25/2023 03:12:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 11:50:27 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM